Photo taken from: Breast Cancer Research Foundation / Webpage
Jul 7, 2023, 10:04
The sample size of the @_SOLTI @GroupeUnicancer RIBOLARIS phase II trial will be increased to 1,100 patients! – Aleix Prat
Very happy to announce that the sample size of the @_SOLTI @GroupeUnicancer RIBOLARIS phase II trial will be increased to 1,100 patients!
Ribolaris trial design: https://bit.ly/3JQ3iBO
https://classic.clinicaltrials.gov/ct2/show/NCT05296746
Very happy to lead this project together with Prof. Paul Cottu, Prof. @GavilKino and Prof. Thibault de La Motte Rouge
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 30, 2025, 17:19
Mar 30, 2025, 16:56
Mar 30, 2025, 16:44
Mar 30, 2025, 16:43
Mar 30, 2025, 16:03
Mar 30, 2025, 15:52
Mar 30, 2025, 15:48